RLMD

#2232
Relmada Therapeutics, Inc. - Common Stock
7.2 1 USD
-0.55%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
7.21
7.21
Year Range
0.52
8.00
Daily Change
-0.55%
Monthly Change
-3.09%
6 month change
+60.22%
Year Change
+887.67%
Previous Close
7.2 5
Open
7.2 1
Low
7.2 1
High
7.2 1
Volume
80
Open full chart Full chart

Financials

Overview Statement Statistics
Quarterly Annual
  • Market Capitalization 756.26 M
  • Employee 17
  • Founded 2004
  • CEO N/A
  • Website www.relmada.com
  • Headquarter Nevada, United States
  • FIGI BBG003MKSL16
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.33
Price to sales ratio
-2 407.45

News